An observational study in Suspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria, sponsored by Alteco Medical AB. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-20.
Sponsored by Alteco Medical AB · Observational
This registry will collect and validate regulatory-grade real-world data (RWD) on the usage of the LPS-Adsorber and the outcomes from using the LPS-Adsorber in various patient populations (various sub-registries) that also have suspected endotoxemia. This data can be then used in real-world evidence (RWE) generation. It will also create reusable infrastructure to allow creation or affiliation with many additional RWD/RWE efforts both prospective and retrospective in nature.
81 studies on the registry are indexed under Endotoxemia; 7 are open to participants now.
Browse Endotoxemia studies →Alteco Medical AB is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with suspected or diagnosed sepsis caused by gram-negative bacteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Specific sub-registry criteria are possible.
Exclusion Criteria:
Patients not treated with LPS Adsorber
Patients treated with LPS Adsorber
Device: LPS Adsorber
LPS Adsorber, binding endotoxin caused by suspected or verified gram-negative bacteria.
The primary endpoint will be the time needed to achieve patient stabilization from the time of treatment.
Time frame: 30 days
Secondary Outcomes will be to document the change in a patient's symptoms of infection over time.
Time frame: 30 days
Rate of complaints and incidents related to the medical device during the whole registry.
Time frame: 30 days
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is withdrawn, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alteco Medical AB